The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of Acetyl Glucosamine, Glucosamine, Glucosamine HCl, and Glucosamine Sulfate. Two of the ingredients, Acetyl Glucosamine and Glucosamine Sulfate, are reported to function in cosmetics as skin-conditioning agents, Glucosamine HCl is reported to function as a pH adjustor, and the function of Glucosamine in cosmetics is not reported. The Panel reviewed the available data and concluded that these glucosamine ingredients are safe in cosmetics in the present practices of use and concentration described in this safety assessment when formulated to be non-irritating.
KellyGS. The role of glucosamine sulfate and chondroitin sulfates in the treatment of degenerative joint disease. Alternative Med Rev. 1998;3(1):27-39.
5.
GarnerSTJr.IsraelBJAchmedHCapomacchiaACAbneyTAzadiP. Transdermal permeability of N-acetyl-D-glucosamine. Pharm Dev Technol. 2007;12(2):169-174.
2004. Estimation Programs Interface SuiteTM Ver 3.12. Washington, DC, USA: United States Environmental Protection Agency.
8.
BichselYvon GuntenU. Formation of iodo-trihalomethanes during disinfection and oxidation of iodide-containing waters. Environ Sci Technol. 2000;34(13):2784-2791.
PerkinElmer Inc. Chemdraw Pro. Chemdraw Pro, 14.0. 2021.
15.
ChenJShenCLiuC. N-Acetylglucosamine: production and applications. Mar Drugs. 2010;8:2493-2516.
16.
French Agency for Food, Environmental, and Occupational Health & Safety. Opinion of the French Agency on Food, Environmental, and Occupational Health & Safety on the risks associated with the consumption of food supplements for joint conditions containing glucosamine and/or chondroitin sulphate. 2019. ANSES opinion request no 2015-SA-0069.
17.
European Food Safety Authority (EFSA). Opinion on the safety of glucosamine hydrochloride from Aspergillus niger as food ingredient. EFSA J. 2009;1099:1-19.
18.
KimYSLeeSJChoiJY, et al.Determination of process-related impurities in N-acetylglucosamine prepared by chemical and enzymatic methods: structural elucidation and quantification. Arch Pharm Res. 2016;39(7):937-945.
19.
U.S. Pharmacopeia. United States Pharmacopeia - National Formulary Online. 2021. https://www.usp.org/. Accessed August 10, 2021.
20.
JungAYHeoMJKimYH. Glucosamine has an antiallergic effect in mice with allergic asthma and rhinitis. Int Forum Allergy Rhinol. 2017;7(8):763-769.
21.
US Food and Drug Administration (FDA) Center for Food Safety & Applied Nutrition (CFSAN). Voluntary cosmetic registration program - frequency of use of cosmetic ingredients. (Obtained under the freedom of information act from CFSAN; Requested as “Frequency of use data”). 2022.
22.
Personal Care Products Council. Concentration of use by FDA product category: glucosamine ingredients. 2020. Unpublished data submitted by the personal care products council on February 28, 2020.
DahmerSSchillerRM. Glucosamine. Am Fam Physician. 2008;78(4):471-476.
25.
BhathalASpryszakMLouizosCFrankelG. Glucosamine and chondroitin use in canines for osteoarthritis: a review. Open Vet J. 2017;7(1):36-49.
26.
BissettDLRobinsonLRRaleighPS, et al.Reduction in the appearance of facial hyperpigmentation by topical N-acetyl glucosamine. J Cosmet Dermatol. 2007;6(1):20-26.
27.
HanIHChoiSNamDY, et al.Identification and assessment of permeability enhancing vehicles for transdermal delivery of glucosamine hydrochloride. Arch Pharm Res. 2010;33(2):293-299.
28.
KanwischerMKimSYKimJSBianSKwonKAKimDD. Evaluation of the physicochemical stability and skin permeation of glucosamine sulfate. Drug Dev Ind Pharm. 2005;31(1):91-97.
29.
KongMHashimKBLinP, et al.Penetration of topical glucosamine sulfate into the synovial fluid of patients with knee osteoarthritis: a non-randomized, open-label, single dose, bioavailability study. J Biosci Med. 2019;7(11):76-90.
30.
MartinezSELillicoRLakowskiTMMartinezSADaviesNM. Pharmacokinetic analysis of an oral multicomponent joint dietary supplement (phycox(®)) in dogs. Pharmaceutics. 2017;9(3):30.
31.
SetnikarIGiachettiCZanoloG. Absorption, distribution and excretion of radioactivity after a single intravenous or oral administration of [14C] glucosamine to the rat. Pharmatherapeutica. 1984;3(8):538-550.
32.
WuHLiuMWangS, et al.Comparative fasting bioavailability and pharmacokinetic properties of 2 formulations of glucosamine hydrochloride in healthy Chinese adult male volunteers. Arzneimittelforschung. 2012;62(8):367-371.
33.
PersianiSRovatiLPastoriniE, et al.Pharmacokinetics of glucosamine in man after oral administration of crystalline glucosamine sulfate or glucosamine hydrocholoride alone or in combination with chondroitin sulfate. Osteoarthr Cartil. 2007;15(Suppl C):C223-C224.
34.
AndersonJWNicolosiRJBorzellecaJF. Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy. Food Chem Toxicol. 2005;43(2):187-201.
35.
EchardBWTalpurNAFunkKABagchiDPreussHG. Effects of oral glucosamine and chondroitin sulfate alone and in combination on the metabolism of SHR and SD rats. Mol Cell Biochem. 2001;225(1):85-91.
36.
LeeKYShibutaniMTakagiH, et al.Subchronic toxicity study of dietary N-acetylglucosamine in F344 rats. Food Chem Toxicol. 2004;42(4):687-695.
37.
KubomuraDUenoTYamadaMTomonagaANagaokaI. Effect of N-acetylglucosamine administration on cartilage metabolism and safety in healthy subjects without symptoms of arthritis: a case report. Exp Ther Med. 2017;13(4):1614-1621.
38.
LefflerCTPhilippiAFLefflerSGMosureJCKimPD. Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study. Mil Med. 1999;164(2):85-91.
39.
TakahashiMInoueKYoshidaMMorikawaTShibutaniMNishikawaA. Lack of chronic toxicity or carcinogenicity of dietary N-acetylglucosamine in F344 rats. Food Chem Toxicol. 2009;47(2):462-471.
40.
FengCYuanTWangS, et al.Glucosamine supplementation in premating drinking water improves within-litter birth weight uniformity of rats partly through modulating hormone metabolism and genes involved in implantation. BioMed Res Int. 2020;2020:1630890.
41.
SchelbachCJRobkerRLBennettBDGauldADThompsonJGKindKL. Altered pregnancy outcomes in mice following treatment with the hyperglycaemia mimetic, glucosamine, during the periconception period. Reprod Fertil Dev. 2013;25(2):405-416.
42.
TsaiJHSchulteMO’NeillKChiMMYFrolovaAIMoleyKH. Glucosamine inhibits decidualization of human endometrial stromal cells and decreases litter sizes in mice. Biol Reprod. 2013;89(1):16.
43.
JamialahmadiKSoltaniFNabavi FardMBehravanJMosaffaF. Assessment of protective effects of glucosamine and N-acetyl glucosamine against DNA damage induced by hydrogen peroxide in human lymphocytes. Drug Chem Toxicol. 2014;37(4):427-432.
44.
ChekiMJafariSNajafiMMahmoudzadehA. Glucosamine protects rat bone marrow cells against cisplatin-induced genotoxicity and cytotoxicity. Anti Cancer Agents Med Chem. 2019;19(14):1695-1702.
45.
WangLSChenSJZhangJFLiuMNZhengJHYaoXD. Anti-proliferative potential of Glucosamine in renal cancer cells via inducing cell cycle arrest at G0/G1 phase. BMC Urol. 2017;17(1):38.
46.
ZhangLLiuWHanBPengYWangD. Antitumor activities of D-glucosamine and its derivatives. J Zheijang Univ Sci B. 2006;7(8):608-614.
47.
BissettDLFarmerTMcPhailS, et al.Genomic expression changes induced by topical N-acetyl glucosamine in skin equivalent cultures in vitro. J Cosmet Dermatol. 2007;6(4):232-238.
48.
WuttikulKBoonmePThammaratCKhongkowP. N-acetylglucosamine microemulsions: assessment of skin penetration, cytotoxicity, and anti-melanogenesis. J Cosmet Dermatol. 2021;20(1):304-309.
49.
HwangJSLeeHYLimTYKimMYYoonTJ. Disruption of tyrosinase glycosylation by N-acetylglucosamine and its depigmenting effects in guinea pig skin and in human skin. J Dermatol Sci. 2011;63(3):199-201.
50.
KimballABKaczvinskyJRLiJ, et al.Reduction in the appearance of facial hyperpigmentation after use of moisturizers with a combination of topical niacinamide and N-acetyl glucosamine: results of a randomized, double-blind, vehicle-controlled trial. Br J Dermatol. 2010;162(2):435-441.
51.
SchlessingerJGreenBEdisonBLMurphyLSabherwalY. Scientific poster: A firming neck cream containing N-acetyl glucosamine significantly improves signs of aging on the challenging neck and décolletage. March 20-24, 2015. San Francisco, CA.
52.
YoonHSByunJWShinJKimYHChoiGS. Therapeutic effect of glucosamine on an atopic dermatitis animal model. Ann Dermatol. 2019;31(5):538-544.
53.
SakaiSSugawaraTKishiTYanagimotoKHirataT. Effect of glucosamine and related compounds on the degranulation of mast cells and ear swelling induced by dinitrofluorobenzene in mice. Life Sci. 2010;86(9-10):337-343.
54.
JinSLimWSungNHCheongKALeeA. Combination of glucosamine and low-dose cyclosporine for atopic dermatitis treatment: a randomized placebo-controlled, double-blind, parallel clinical trial. Dermatol Ther. 2015;28(1):44-51.
55.
Anonymous. 21-day cumulative irritation patch test (eye cream with 2% Acetyl Glucosamine). 2006.
56.
Anonymous. Epeat insult patch test (mask contains 0.005% Acetyl Glucosamine). 2018. Unpublished data submitted by the personal care products council on February 19, 2021.
57.
BjerkeDLKernPDeConinckW. Skin sensitization next generation risk assessment framework and case study. 2022. Unpublished information presented to the expert panel for cosmetic ingredient safety on March 7, 2022.
58.
TKL Research. Human repeat insult patch test (liquid foundation with 2% Acetyl Glucosamine). 2011.
59.
Anonymous. Clinical safety evaluation repeated insult patch test (leave-on product containing 0.005% Glucosamine HCl). 2012. Unpublished data submitted by Personal care products council on April 29, 2021.
60.
Anonymous. An evaluation of the contact sensitization potential of a topical coded product in human skin by means of the maximization assay (product contains 0.01% Glucosamine). 2005. Unpublished data submitted by personal care products council on February 19, 2021.
61.
Anonymous. An evaluation of the contact sensitization potential of a topical coded product in human skin by means of the maximization assay (product contains 0.25% Glucosamine HCl). 2007. Unpublished data submitted by personal care products council on February 19, 2021.
62.
Institute for In Vitro Sciences Inc. Tissue equivalent assay with Epiocular™ cultures (face serum with 2% Acetyl Glucosamine). 2009.
TalliaAFCardoneDA. Asthma exacerbation associated with glucosamine-chondroitin supplement. J Am Board Fam Pract. 2002;15(6):481-484.
65.
GueyeSSaint-CricqMCoulibalyM, et al.Chronic tubulointerstitial nephropathy induced by glucosamine: a case report and literature review. Clin Nephrol. 2016;86(2):106-110.
66.
MatheuVGracia BaraMTPeltaRVivasERubioM. Immediate-hypersensitivity reaction to glucosamine sulfate. Allergy. 1999;54(6):643.
67.
KantorEDNewtonCCGiovannucciELMcCulloughMLCampbellPTJacobsEJ. Glucosamine use and risk of colorectal cancer: results from the cancer prevention study II nutrition cohort. Cancer Causes Control. 2018;29(3):389-397.
68.
BraskyTMLampeJWSlatoreCGWhiteE. Use of glucosamine and chondroitin and lung cancer risk in the vitamins and lifestyle (VITAL) cohort. Cancer Causes Control. 2011;22(9):1333-1342.
